Henry Schein, Inc.

January 11, 2005 07:00 ET

Henry Schein Acquires Ash Temple, a Canadian Full-Service Dental Distributor


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: HENRY SCHEIN, INC.

NASDAQ SYMBOL: HSIC

JANUARY 11, 2005 - 07:00 ET

Henry Schein Acquires Ash Temple, a Canadian
Full-Service Dental Distributor

MELVILLE, N.Y.--(CCNMatthews - Jan 11, 2005) -

Henry Schein, Inc. (Nasdaq NM: HSIC), the largest provider of healthcare
products and services to office-based practitioners in the combined
North American and European markets, today announced that it has
acquired the dental distribution business of Ash Temple Limited (ATL), a
privately held full-service dental distributor based in Concord,
Ontario, with revenues of approximately USD $100 million in the last
fiscal year. The acquisition is expected to be immediately accretive to
Henry Schein. Terms of the transaction were not disclosed.

First established over 100 years ago, ATL operations will be combined
with Henry Schein Arcona, Henry Schein's Canadian dental business, and
operate under the new name Henry Schein Ash Arcona. Through the
acquisition, Henry Schein Arcona's 100-person dental sales force will
double as the new entity provides dental practitioners across Canada
with a full range of dental products and services.

"Combining our Henry Schein Arcona operations with Ash Temple is an
ideal strategic and cultural fit, and firmly positions us as the leading
dental company in the expanding market for dental merchandise and
equipment in Canada," said Stanley M. Bergman, Chairman, Chief Executive
Officer and President of Henry Schein. "We believe the addition of Ash
Temple, with its broad presence across Canada and strength in dental
equipment and laboratory products, will perfectly complement Henry
Schein's strong expertise in logistics as well as in the marketing and
merchandising of dental consumables. We look forward to Henry Schein Ash
Arcona offering customers the many benefits of the newly combined entity
and providing dental practitioners and laboratories with the highest
level of quality products and services for all their practice needs."

"Henry Schein first entered the Canadian market in the late 1980s and we
have continuously increased our presence in this important market,
including acquiring Arcona in 1998, continued Mr. Bergman. "We are very
excited now to be adding Ash Temple, a company rich with tradition and
history, and pleased that the Ash Temple team members will be joining
Team Schein. We are particularly pleased that the strong senior
management of both teams will combine their talents to guide Henry
Schein Ash Arcona. We are very pleased to welcome Michel Hart, the
Chairman and CEO of Ash Temple, who will assume the position of Chairman
of the new entity, and Cy Elborne, the President and Chief Operating
Officer of Ash Temple, who will manage the Henry Schein Ash Arcona sales
force in the position of Executive Vice President, Sales. Joe Robertson
and Carman Adair of Henry Schein Arcona will assume the roles of
President, and Chief Operating Officer, respectively, for Henry Schein
Ash Arcona."

"We are delighted to become part of Henry Schein and to offer our
customers a total solution including a greater variety of dental
operatory and laboratory merchandise, equipment, software and more,"
said Mr. Hart. "Ash Temple, like Henry Schein, is built upon a
commitment to providing the highest level of customer service, and we
look forward to the many business opportunities we face in concert with
Henry Schein Arcona."

About Ash Temple Ltd.

With a history that dates to 1895, Ash Temple offers dental supplies,
equipment, artificial teeth and repair parts, as well as services
including office design and planning, equipment lease financing and
limited consulting. Built on a tradition of integrity and quality, Ash
Temple is one of the largest diversified dental companies in Canada with
14 branches including five distribution centers. Ash Temple services all
10 Canadian provinces and three territories, while operating under the
name Servident in Quebec. Ash Temple serves approximately 17,200
dentists, 2,200 laboratory technicians and 2,000 denturists.

About Henry Schein

Henry Schein, a Fortune 500® company, is recognized for its excellent
customer service and highly competitive prices. The Company's four
business groups - Dental, Medical, International and Technology - serve
more than 450,000 customers worldwide, including dental practices and
laboratories, physician practices and veterinary clinics, as well as
government and other institutions.

The Company's sales reached a record $3.4 billion in 2003. Henry Schein
operates through a centralized and automated distribution network, which
provides customers in more than 125 countries with a comprehensive
selection of over 90,000 national and Henry Schein private-brand
products.

Henry Schein also offers a wide range of innovative value-added practice
solutions, including such leading practice management software systems
as DENTRIX® and Easy Dental® for dental practices, and AVImark®
for veterinary clinics, which are installed in over 50,000 practices;
and ArubA®, Henry Schein's electronic catalog and ordering system.

Headquartered in Melville, N.Y., Henry Schein employs nearly 10,000
people and has operations in 17 countries. For more information, visit
the Henry Schein Web site at www.henryschein.com.

In accordance with the "Safe Harbor" provisions of the Private
Securities Litigation Reform Act of 1995, the Company provides the
following cautionary remarks regarding important factors which, among
others, could cause future results to differ materially from the
forward-looking statements, expectations and assumptions expressed or
implied herein. All forward-looking statements made by us are subject to
risks and uncertainties and are not guaranties of future performance.
These forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company's actual
results, performance and achievements, or industry results to be
materially different from any future results, performance, or
achievements expressed or implied by such forward-looking statements.
These statements are identified by the use of such terms as "may,"
"could," "expect," "intend," "believe," "plan," "estimate," "forecast,"
"project," "anticipate," or other comparable terms. A full discussion of
the Company's operations and financial condition, including factors that
may affect its business and future prospects, is contained in documents
the Company has filed with the SEC and will be contained in all
subsequent periodic filings made with the SEC. These documents identify
in detail important risk factors that could cause the Company's actual
performance to differ materially from current expectations.

Risk factors and uncertainties which could cause actual results to
differ materially from current and historical results include, but are
not limited to: competitive factors; changes in the healthcare industry;
changes in government regulations that affect the Company; financial
risks associated with the Company's international operations;
fluctuations in quarterly earnings; transitional challenges associated
with acquisitions; regulatory and litigation risks; the dependence on
the Company's continued product development, technical support and
successful marketing in the technology segment; the Company's dependence
upon sales personnel and key customers; the Company's dependence on its
senior management; the Company's dependence on third parties for the
manufacture and supply of its products; possible increases in the cost
of shipping the Company's products or other service trouble with the
Company's third-party shippers; risks from rapid technological change;
and risks from potential increases in variable interest rates.

The order in which these factors appear should not be construed to
indicate their relative importance or priority. The Company cautions
that these factors may not be exhaustive and that many of these factors
are beyond the Company's ability to control or predict. Accordingly,
forward-looking statements should not be relied upon as a prediction of
actual results. The Company undertakes no duty and has no obligation to
update forward-looking statements.

-30-

Contact Information